Malaysia Expands Medical Device Regulation to Aesthetic Treatment Technologies

On February 25, 2026, the Medical Device Authority (MDA) of Malaysia announced the gazettement of the “Medical Device (Designated Medical Devices) Order 2026,” introducing regulatory controls for selected devices used in aesthetic and cosmetic medical procedures.

The Order will take effect on June 1, 2026, bringing these technologies within Malaysia’s medical device regulatory framework.

Malaysia Introduces Regulatory Oversight for Aesthetic Medical Devices

Malaysia’s aesthetic and cosmetic treatment sector has grown rapidly, increasing the use of advanced technologies in medical and wellness settings. The new Order introduces formal regulatory oversight for devices used in these procedures, requiring affected products to comply with Malaysia’s medical device regulatory framework.

For manufacturers and distributors supplying aesthetic treatment technologies, the change introduces clear requirements related to product registration, safety evaluation, and market authorization.

Objectives of the Medical Device (Designated Medical Devices) Order 2026

According to the Medical Device Authority, the Order is intended to strengthen safety oversight for aesthetic medical procedures while supporting responsible use of medical technologies.

Key objectives include:

• Strengthening control over medical devices used in aesthetic and cosmetic treatments
• Ensuring devices meet appropriate safety, quality, and performance standards
• Enhancing consumer protection through regulatory oversight
• Promoting responsible clinical use of aesthetic medical technologies

Aesthetic Medical Devices Covered Under the Order

The Order designates several technologies commonly used in aesthetic procedures as regulated medical devices.

Devices covered include:

• Laser-based medical devices used in aesthetic procedures
• High-Intensity Focused Ultrasound (HIFU) systems
• Liposuction devices
• Other related aesthetic and cosmetic medical technologies

Once designated, these devices may require formal medical device registration in Malaysia, along with applicable conformity assessment and regulatory review.

Practitioner Qualification Requirements

The Order also emphasizes that designated devices must be used by qualified and competent practitioners recognized by the relevant authorities.

This requirement aims to reduce risks associated with improper device use and ensure aesthetic procedures are performed under appropriate professional supervision.

Regulatory Implications for Manufacturers

Companies supplying aesthetic medical technologies should assess whether products fall within the scope of the new designation.

Where applicable, manufacturers may need to:

• Confirm device registration requirements with the Medical Device Authority
• Prepare or update technical documentation
• Ensure labeling and intended use align with regulatory expectations
• Appoint an authorized representative to maintain compliance in Malaysia

Early regulatory review will help companies avoid delays once the Order becomes effective on June 1, 2026.

What This Means for Companies Operating in Malaysia

The “Medical Device (Designated Medical Devices) Order 2026” signals a clear regulatory shift for aesthetic treatment technologies in Malaysia. Devices that may previously have operated in a regulatory gray area will now fall under the country’s formal medical device framework, increasing scrutiny on product classification, documentation, and market authorization.

For manufacturers already supplying aesthetic technologies in Malaysia — or planning market entry — the priority should be confirming regulatory status and preparing for potential registration or conformity assessment requirements before the June 1, 2026, implementation date.

To support companies navigating these requirements, Cisema provides regulatory compliance services for international medical device manufacturers operating in Malaysia and across the Asia-Pacific region, including:

• Independent Authorized Representative and license holding in Malaysia
• Medical device registration and regulatory submission management
• Conformity assessment coordination and regulatory authority liaison
• Regulatory gap analysis and compliance strategy
• Regional regulatory support across Southeast Asia, Hong Kong, Taiwan, and China

Get in touch with Cisema today to discuss how we can support your medical device registration and regulatory compliance strategy in Malaysia and across the Asia-Pacific region.

Further Information

For more details on regulatory pathways and compliance requirements, see Cisema’s medical device registration services for Malaysia.

References

Manufacturers can review the official announcement from the Medical Device Authority in “Medical Device (Designated Medical Devices) Order 2026”